Mumbai, March 04, 2018: Laurus Labs Ltd said that the USFDA audit has been successfully completed without observations – ZERO 483 for its Unit 2 (formulations unit). The inspection was carried out from Feb 26 2018 to March 1, 2018.
Laurus Labs Ltd has also received its maiden Approval from United States Food and Drug Administration (U. S FDA) for Tenofovir Disoproxil Fumarate Tablets 300mg.
Tenofovir Disoproxil Fumarate Tablets 300mg is therapeutically equivalent to VIREAD Tablets 300mg of Gilead Science Ltd.
Corporate Comm India(CCI Newswire)
